The Early Warning System for the Central Nervous System Micro-structure Alterations During Early Diabetes Based on the Multi-mode MRIs

Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY

Diabetes( mainly type II diabetes )lead to the central nervous system (CNS) function impairment, especially the mild cognitive impairment that increased the risk of progression to dementia.The primary objectives are defined according to a hierarchical design: i) to tailor and apply multi-parametric, functional MRI techniques to identify cerebral abnormalities (cerebral biomarkers) in type 2 diabetes mellitus and prodromal diabetes mellitus ; ii) to assess whether these cerebral biomarkers are associated with cognitive decrements;iii) to follow up with the putative prediabetic condition patients to verify whether they can transform into diabetes.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 40
Maximum Age: 65
Healthy Volunteers: t
View:

• without dementia

• Inform Consent Form

• Education time more than 6 years

• blood glucose matches the group standard

Locations
Other Locations
China
Tangdu Hospital
RECRUITING
Xi'an
Contact Information
Primary
Guangbin Cui, professor
cgbtd@126.com
Time Frame
Start Date: 2015-04
Estimated Completion Date: 2026-12
Participants
Target number of participants: 300
Treatments
healthy control group
fasting plasma glucose(FPG)\<6.11mmol/L,and 2-h plasma glucose(2hPG)\<7.77mmol/L;
prodromal diabetes group
IFG:fasting plasma glucose(FPG) ≥5.6mmol/L (100mg/dl),and\<7.0mmol/L (126mg/dl),oral glucose tolerance test(OGTT) 2-h plasma glucose(2hPG) \<7.8 mmol/L ;IGT:oral glucose tolerance test(OGTT) 2-h plasma glucose(2hPG) ≥7.8mmol/L (140mg/dl),and\<11.1mmol/L (200mg/dl),fasting plasma glucose(FPG)\< 5.6mmol/L
diabetes group
fasting plasma glucose(FPG)\>7.0mmol/L, or 2-h plasma glucose(2hPG)\>11.1mmol/L
Sponsors
Leads: Tang-Du Hospital

This content was sourced from clinicaltrials.gov